Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The continuous glucose monitoring (CGM) devices market is experiencing significant growth, driven by advancements in technology and an increasing number of individuals living with diabetes. As healthcare shifts toward more personalized and data-driven management approaches, the demand for effective glucose monitoring solutions continues to rise. Let’s explore the market’s current scale, key factors fueling its expansion, important segments, innovative trends, leading companies, and regional performance.

Continuous Glucose Monitoring Devices Market Size and Growth Outlook

The market for continuous glucose monitoring devices has expanded swiftly in recent years. It is projected to grow from $9.79 billion in 2025 to $11.45 billion in 2026, representing a compound annual growth rate (CAGR) of 16.9%. This growth during the historical period is largely due to the rising prevalence of diabetes across various age groups, greater adoption of home-based glucose monitoring systems, advancements in sensor miniaturization, increasing patient preference for continuous glucose monitoring, and the growing use of digital health technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20733&type=smp

Looking ahead, the market is expected to maintain a robust expansion, reaching $21.13 billion by 2030 with a CAGR of 16.6%. Key factors propelling this forecast include increased demand for interoperable diabetes management devices, rising investments in artificial intelligence-driven glucose prediction tools, growth in remote diabetes care models, a stronger focus on data-driven treatment optimization, and wider adoption of next-generation sensor materials. Prominent trends shaping the market involve greater acceptance of non-invasive CGM technologies, a surge in cloud-connected glucose monitoring systems, expanded use of predictive glucose analytics, development of long-wear sensor solutions, and improvements in user-friendly device designs.

Factors Propelling the Expansion of the Continuous Glucose Monitoring Devices Market

The increasing number of diabetes cases worldwide is a major driver of CGM device market growth. Diabetes, characterized by the body’s inability to properly regulate blood sugar due to insufficient insulin or insulin resistance, is becoming more common because of unhealthy diets, sedentary lifestyles, obesity, aging populations, and genetic factors. CGM devices assist in managing this condition by delivering real-time glucose level information, enabling timely adjustments to treatment and lifestyle.

Access The Complete Continuous Glucose Monitoring Devices Market Report:

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

For instance, data from the UK’s Office for Health Improvement & Disparities in March 2024 indicated that between March 2022 and March 2023, the proportion of type 1 diabetes patients receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, it rose by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded by the National Diabetes Audit. These improvements highlight enhanced diabetes management efforts, which in turn boost demand for continuous glucose monitoring devices.

Breaking Down the Continuous Glucose Monitoring Devices Market Segments

The continuous glucose monitoring devices market can be categorized based on several key factors:

1) Component types such as transmitters, sensors, and receivers;

2) Connectivity options including Bluetooth and 4G;

3) Demographic groups like child and adult populations;

4) Application areas covering gestational diabetes, type-2 diabetes, and type-1 diabetes;

5) End-use settings such as hospitals, homecare environments, and other users.

Within the component segment, transmitters include Bluetooth-enabled transmitters, wireless transmitters, and integrated transmitter-receiver systems. Sensor types feature enzyme-based sensors, electrochemical sensors, and non-invasive sensors. Receivers consist of smartphone-integrated devices, standalone receivers, and cloud-synced data receivers.

Innovative Trends Transforming the Continuous Glucose Monitoring Devices Industry

Leading companies in the CGM market are prioritizing the development of cutting-edge technologies aimed at improving user accessibility, accuracy, and convenience. One notable advancement is the introduction of over-the-counter continuous glucose monitors, which allow individuals to track their glucose levels without a prescription.

For example, in September 2024, Abbott Laboratories launched the Lingo continuous glucose monitoring system, designed to provide real-time glucose information throughout the day. This device features a sleek and user-friendly design with easy-to-read displays, delivering continuous feedback on blood sugar levels. It also integrates smoothly with mobile applications to help users monitor trends and receive alerts, enhancing the overall management experience.

Key Players Driving the Continuous Glucose Monitoring Devices Market Competition

The continuous glucose monitoring devices industry is shaped by several prominent companies, including Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., and Nemaura Medical Inc.

Regional Market Insights with Focus on Revenue and Growth

In 2025, North America was the leading region in terms of revenue and market share for continuous glucose monitoring devices. However, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period. The market report covers a comprehensive range of regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on market trends and development opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model